Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial

Abstract Background Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. Methods The goal of this ra...

詳細記述

書誌詳細

主要な著者:	Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2019-07-01
シリーズ:	Trials
主題:	Nifurtimox Benznidazole Trypanosoma cruzi Chagas disese Randomized controlled trial
オンライン･アクセス:	http://link.springer.com/article/10.1186/s13063-019-3423-3
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!